期刊文献+

氯吡格雷抵抗机制的研究进展 被引量:3

下载PDF
导出
摘要 阿司匹林与氯吡格雷双联抗血小板治疗是急性冠脉综合征(ACS)和经皮冠状动脉介入治疗(PCI)的标准化治疗[1],氯吡格雷是抗血小板药物,通过有效抑制血小板的活化和聚集,其与血小板表面P2Y12受体不可逆结合,从而阻断二磷酸腺苷诱导的血小板聚集。
出处 《国际检验医学杂志》 CAS 2013年第7期843-846,共4页 International Journal of Laboratory Medicine
  • 相关文献

参考文献26

  • 1张灏,米登海主编..抗血小板治疗[M].北京:人民卫生出版社,2011:627.
  • 2Vlachojannis GJ,Dimitropoulos G, Alexopoulos D. Clopidogrel re sistance: current aspects and future directions[J]. Hellenic J Car diol,2011,52(3) :236-245. 被引量:1
  • 3Bozbeyoglu E,Satilmis S,Aksu H, et al. Impact of clopidogrel re- sistance on ST-segment resolution and no reflow in acute myocar- dial infarction with ST-elevation patients treated with a primary percutaneous coronary intervention [ J ]. Coron Artery Dis, 2012, 23(8) 523-527. 被引量:1
  • 4Alexander SP, Mathie A,Peters JA. Guide to receptors and chan nels (GRAC) ,4th edition[J]. Br J Pharmacol,2009,158 Suppl 1 S1-254. 被引量:1
  • 5Angiolillo DJ. Variability in responsiveness to oral antiplatelet therapy [J]. Am J Cardiol, 2009,103 (3 Suppl) : 27A-34A. 被引量:1
  • 6Bonello L, Camoin-Jau L, Arques S, et al. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascu- lar events in patients with clopidogrel resistance: a multicenter randomized prospective study [J ]. J Am Coll Cardiol, 2008, 51 (14) : 1404-1411. 被引量:1
  • 7Dupont AG,Gabriel DA, Cohen MG. et al. Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndrome[J]. Thromb Res,2009,124(1) :6 13. 被引量:1
  • 8Mega JL,Close SL,Wiviott SD,et al. Cytochrome p-450 polymor- phisms and response to clopidogrel[J]. N Engl J Med, 2009,360 (4) :354-362. 被引量:1
  • 9Gurbel PA,Tantry US. Clopidogrel resistance? [J]. Thromb Res, 2007,120(3) : 311-321. 被引量:1
  • 10Pena A,Collet JP, Hulot JS,et al. Can we override clopidogrel re- sistance? [J]. Circulation, 2009,119 (21 ) : 2854-2857. 被引量:1

二级参考文献26

  • 1Porto I, Van Gaal W, Banning A. Impact of the elevation of biochemical markers of myocardial damage on long term mortality after percutaneous coronary intervention: results of theCK MBand PCI study[J]. Eur Heart J, 2005,26(20): 2206-2207. 被引量:1
  • 2Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction[J]. J Am Coll Cardiol, 2009,54 (23) : 2157-2163. 被引量:1
  • 3Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early pereutaneous coronary intervention: results of the ARMYDA ACS randomized trial [J]. J Am Coll Cardiol, 2007,49(12) :1272- 1278. 被引量:1
  • 4Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention : results of the ARMYDA RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial [J]. J AmCollCardiol, 2009,54(6):558 -565. 被引量:1
  • 5Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives[J]. J Am Coll Cardiol, 2007,49(14) :1505 -1516. 被引量:1
  • 6Marian AJ. Cytochrome p-450 polymorphisms and response to clopidogrel[J]. Curr Atheroscler Rep, 2009,11(3):157-160. 被引量:1
  • 7Neubauer H, Gtinesdogan B, Hanefeld C, et al. Lipophilic statins interfere with the inhibitory effects of elopidogrel on platelet function-a flow cytometry study[J]. Eur Heart J, 2003,24(19) : 1744-1749. 被引量:1
  • 8Brophy JM, Babapulle MN, Costa V, et al. A pharmacoe pidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention[J]. Am Heart J, 2006,152(2) :263 -269. 被引量:1
  • 9Saw J, Brennan DM, Steinhubl SR,et al. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial[J]. J Am Coll Cardiol, 2007,50(4):291-295. 被引量:1
  • 10Lim MJ, Spencer FA, Gore JM, et al. Impact of combined pharmacologic treatment with elopidogrel and a statin on outcomes of patients with non-ST segment elevation acute coronary syndromes: perspectives from a large multinational registry[J]. Eur Heart J, 2005, 26(11):1063-1069. 被引量:1

共引文献19

同被引文献27

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部